DrugPatentWatch Database Preview

ONZETRA XSAIL Drug Profile

« Back to Dashboard

Which patents cover Onzetra Xsail, and what generic alternatives are available?

Onzetra Xsail is a drug marketed by Avanir Pharms and is included in one NDA. There are thirteen patents protecting this drug.

The generic ingredient in ONZETRA XSAIL is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

Summary for ONZETRA XSAIL

US Patents:	13
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	80
Clinical Trials:	1
Patent Applications:	3,896
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for ONZETRA XSAIL
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for ONZETRA XSAIL
DailyMed Link:	ONZETRA XSAIL at DailyMed

Synonyms for ONZETRA XSAIL

(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide

(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide #

1-(3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide

1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide

1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide

1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide

1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide

103628-46-2

103628-48-4 (succinate)

1H-Indole-5-methanesulfonamide, 3-(2-(dimethylamino)ethyl)-N-methyl-

3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide

3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole -5-methanesulphonamide

3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide

3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide

3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide

628S462

8R78F6L9VO

AB0016356

AB00698285_14

AB00698285_15

AB00698285-12

AB00698285-13

AC1L1K6B

AJ-08373

AKOS015894924

Ambap103628-46-2

AN-5271

API0004291

AVP 825

AVP-825

AVP825

BDBM50005835

BIDD:GT0248

BRD-K50938287-001-01-7

BRN 6930870

BSPBio_002304

C07319

C14H21N3O2S

CAS-103628-46-2

CCG-230331

CHEBI:10650

CHEMBL128

D00451

D0Z6UC

DB00669

DR001144

DSSTox_CID_3628

DSSTox_GSID_23628

DSSTox_RID_77118

DTXSID4023628

FT-0631027

GR 43175

GR 43175X

GR-43175

GR43175

GTPL54

HE291385

HMS2231B21

HMS3369A05

HSDB 7742

I06-0076

Imigran (TN)

Imigran Recovery

Imitrex (TN)

Imitrex Oral

Imitrex, Imigran ,Treximet

J-001014

KB-217141

KQKPFRSPSRPDEB-UHFFFAOYSA-N

KS-1116

L000584

LS-83175

MCULE-3991948648

MLS001195659

MLS001304742

MolPort-002-885-863

NCGC00095838-01

NCGC00095838-02

NCGC00095838-03

NCGC00095838-04

NP101

O262

SBI-0206837.P001

SC-18016

SCHEMBL1482

SMR000596517

SPECTRUM1505372

STL451003

Sumatran

sumatriptan

Sumatriptan (JAN/USP/INN)

Sumatriptan [USP:INN:BAN]

Sumatriptanum

Sumatriptanum [INN-Latin]

Sumax

Tox21_111528

Tox21_111528_1

UNII-8R78F6L9VO

Zecuity

Zembrace SymTouch

ZINC14360

US Patents and Regulatory Information for ONZETRA XSAIL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Avanir Pharms	ONZETRA XSAIL	sumatriptan succinate	POWDER;INHALATION	206099-001	Jan 27, 2016		RX	Yes	Yes			Y
Avanir Pharms	ONZETRA XSAIL	sumatriptan succinate	POWDER;INHALATION	206099-001	Jan 27, 2016		RX	Yes	Yes			Y
Avanir Pharms	ONZETRA XSAIL	sumatriptan succinate	POWDER;INHALATION	206099-001	Jan 27, 2016		RX	Yes	Yes			Y

International Patents for ONZETRA XSAIL

Country	Document Number	Estimated Expiration
Japan	2014205070
United Kingdom	201000312
United Kingdom	2391482